Bioharvest Sciences Inc (BHSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 138 | 116 | 75 | 60 | 65 |
| Accounts receivable | 50 | -92 | -110 | -114 | -51 |
| Other Working Capital | -77 | 330 | -563 | 214 | -72 |
| Other Operating Activity | -2,397 | -1,783 | -1,278 | -1,363 | -1,188 |
| Operating Cash Flow | $-2,286 | $-1,429 | $-1,876 | $-1,203 | $-1,246 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -354 | -506 | -523 | -257 | -155 |
| Investing Cash Flow | $-354 | $-506 | $-523 | $-257 | $-155 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 0 | 0 | 55 |
| Debt Repayment | -103 | -92 | -68 | -69 | -60 |
| Common Stock Issued | 50 | 2,703 | 0 | 4,713 | 423 |
| Other Financing Activity | 0 | 2,632 | 18 | 988 | -55 |
| Financing Cash Flow | $-53 | $5,243 | $-50 | $5,632 | $363 |
| Exchange Rate Effect | -2 | -1 | -2 | 1 | -4 |
| Beginning Cash Position | 6,812 | 3,505 | 5,956 | 1,783 | 2,825 |
| End Cash Position | 4,117 | 6,812 | 3,505 | 5,956 | 1,783 |
| Net Cash Flow | $-2,693 | $3,308 | $-2,449 | $4,172 | $-1,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,286 | -1,429 | -1,876 | -1,203 | -1,246 |
| Capital Expenditure | -354 | -506 | -523 | -257 | -155 |
| Free Cash Flow | -2,640 | -1,935 | -2,399 | -1,460 | -1,401 |